Vaidya Y, Vaidya P, Vaidya T. Ductal carcinoma in situ of the breast. Indian J Surg. 2015;77(2):141–6. https://doi.org/10.1007/s12262-013-0987-0 (Epub 2013 Oct 12. PMID: 26139969; PMCID: PMC4484537).

Article  PubMed  Google Scholar 

Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010;41:134–8.

Article  Google Scholar 

Ward WH, DeMora L, Handorf E, et al. Preoperative delays in the treatment of DCIS and the associated incidence of invasive breast cancer. Ann Surg Oncol. 2020;27:386–96. https://doi.org/10.1245/s10434-019-07844-4.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442 (Epub 2018 Jan 4 PMID: 29313949).

Article  PubMed  Google Scholar 

Kong J, Liu X, Zhang X, Zou Y. The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients. Medicine (Baltimore). 2020;99(28):e20847. https://doi.org/10.1097/MD.0000000000020847 (PMID:32664078;PMCID:PMC7360308).

Article  Google Scholar 

Sundara Rajan S, Verma R, Shaaban AM, Sharma N, Dall B, Lansdown M. Palpable ductal carcinoma in situ: analysis of radiological and histological features of a large series with 5-year follow-up. Clin Breast Cancer. 2013;13(6):486–91. https://doi.org/10.1016/j.clbc.2013.08.002 (PMID: 24267733).

Article  PubMed  Google Scholar 

Gooch JC, Chun J, Kaplowitz E, Kurz E, Guth A, Lee J, Schnabel F. Breast density in a contemporary cohort of women with ductal carcinoma in situ (DCIS). Ann Surg Oncol. 2019;26(11):3472–7. https://doi.org/10.1245/s10434-019-07479-5 (Epub 2019 May 30 PMID: 31147991).

Article  PubMed  Google Scholar 

Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2006;97(2):135–44.

Article  Google Scholar 

Wang LC, Sullivan M, Du H, Feldman MI, Mendelson EB. US appearance of ductal carcinoma in situ. Radiographics. 2013;33(1):213–28. https://doi.org/10.1148/rg.331125092.

Article  PubMed  Google Scholar 

Parikh U, Chhor CM, Mercado CL. Ductal carcinoma in situ: the whole truth. AJR Am J Roentgenol. 2018;210(2):246–55. https://doi.org/10.2214/AJR.17.18778.

Article  PubMed  Google Scholar 

Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol biomark prev publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2005;14(4):1008–11. https://doi.org/10.1158/1055-9965.EPI-04-0849.

Article  Google Scholar 

Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8. https://doi.org/10.1093/jnci/djp482 (Epub 2010 Jan 13 PMID: 20071685).

Article  PubMed  Google Scholar 

Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76(7):1197–200 (PMID: 8630897).

CAS  Article  Google Scholar 

Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses’ Health Study. Cancer. 2005;103(9):1778–84. https://doi.org/10.1002/cncr.20979 (PMID: 15770688).

Article  PubMed  Google Scholar 

Williams KE, Barnes NLP, Cramer A, Johnson R, Cheema K, Morris J, Howe M, Bundred NJ. Molecular phenotypes of DCIS predict overall and invasive recurrence. Ann Oncol. 2015;26(5):1019–25. https://doi.org/10.1093/annonc/mdv062 (Epub 2015 Feb 12 PMID: 25678586).

CAS  Article  PubMed  Google Scholar 

Giannakeas V, Sopik V, Narod SA. A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis. Breast Cancer Res Treat. 2018;169(3):587–94. https://doi.org/10.1007/s10549-018-4716-z.

Article  PubMed  Google Scholar 

Giannakeas V, Sopik V, Narod SA. Association of a diagnosis of ductal carcinoma in situ with death from breast cancer. JAMA Netw Open. 2020;3(9):e2017124. https://doi.org/10.1001/jamanetworkopen.2020.17124.

Article  PubMed  PubMed Central  Google Scholar 

Tavassoli FA. Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification. Nat Clin Pract Oncol. 2005;2(3):116–7. https://doi.org/10.1038/ncponc0109 (PMID: 16264885).

Article  PubMed  Google Scholar 

Pinder SE. Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. Mod Pathol. 2010;23(Suppl 2):S8-13. https://doi.org/10.1038/modpathol.2010.40 (PMID: 20436505).

Article  PubMed  Google Scholar 

Zhang X, Dai H, Liu B, Song F, Chen K. Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis. Eur J Cancer Prev. 2016;25(1):19–28. https://doi.org/10.1097/CEJ.0000000000000131 (PMID:25714649;PMCID:PMC4885540).

CAS  Article  PubMed  Google Scholar 

Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103(12):2481–4. https://doi.org/10.1002/cncr.21069 (PMID: 15884091).

Article  PubMed  Google Scholar 

Yeong J, Thike AA, Tan PH, Iqbal J. Identifying progression predictors of breast ductal carcinoma in situ. J Clin Pathol. 2017;70(2):102–8. https://doi.org/10.1136/jclinpath-2016-204154 (Epub 2016 Nov 18 PMID: 27864452).

CAS  Article  PubMed  Google Scholar 

Correa C, McGale P, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;41:162–77.

Google Scholar 

Giannakeas V, Sopik V, Narod SA. Association of radiotherapy with survival in women treated for ductal carcinoma in situ with lumpectomy or mastectomy. JAMA Netw Open. 2018;1(4):e181100.

Article  Google Scholar 

Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28:3762–9.

Article  Google Scholar 

Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010;102(9):627–37. https://doi.org/10.1093/jnci/djq101.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Solin LJ, et al. A Multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2013;105(10):701–10.

CAS  Article  Google Scholar 

Whitney J, Corredor G, Janowczyk A, Ganesan S, Doyle S, Tomaszewski J, Feldman M, Gilmore H, Madabhushi A. Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer. BMC Cancer. 2018;18(1):610. https://doi.org/10.1186/s12885-018-4448-9 (PMID:29848291;PMCID:PMC5977541).

Article  PubMed  PubMed Central  Google Scholar 

Durrani S, Al-Mushawa F, Heena H, Wani T, Al-Qahtani A. Relationship of oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and nottingham prognostic index in early breast cancer tumors in Saudi population. Ann Diagn Pathol. 2021;51:151674. https://doi.org/10.1016/j.anndiagpath.2020.151674.

Article  PubMed  Google Scholar 

Huang Z, Qin Q, Xia L, Lian B, Tan Q, Yu Y, Mo Q. significance of oncotype DX 21-gene test and expression of long non-coding RNA MALAT1 in early and estrogen receptor-positive breast cancer patients. Cancer Manag Res. 2021;22(13):587–93. https://doi.org/10.2147/CMAR.S276795 (PMID:33519238;PMCID:PMC7837574).

Article  Google Scholar 

Baehner FL. The analytical validation of the oncotype DX Recurrence Score assay. Ecancermedicalscience. 2016;26(10):675. https://doi.org/10.3332/ecancer.2016.675 (PMID:27729940;PMCID:PMC5045300).

Article  Google Scholar 

Pennock ND, Jindal S, Horton W, Sun D, Narasimhan J, Carbone L, Fei SS, Searles R, Harrington CA, Burchard J, Weinmann S, Schedin P, Xia Z. RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery. BMC Med Genomics. 2019;12(1):195. https://doi.org/10.1186/s12920-019-0643-z (PMID:31856832;PMCID:PMC6924022).

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cohen PA, Loudig O, Liu C, Albanese J, Fineberg S. The ZNF217 biomarker predicts low- and high-risk oncotype DX® recurrence score in ER-positive invasive breast cancers. Front Pharmacol. 2019;28(10):524. https://doi.org/10.3389/fphar.2019.00524 (PMID:31191299;PMCID:PMC6546897).

CAS  Article  Google Scholar 

Nofech-Mozes S, Hanna W, Rakovitch E. Molecular evaluation of breast ductal carcinoma in situ with oncotype DX DCIS. Am J Pathol. 2019;189(5):975–80. https://doi.org/10.1016/j.ajpath.2018.12.003.

CAS  Article  PubMed  Google Scholar 

Paszat L, Sutradhar R, Zhou L, Nofech-Mozes S, Rakovitch E. Including the ductal carcinoma in situ (DCIS) Score in the development of a multivariable prediction model for recurrence after excision of DCIS. Clin Breast Cancer. 2018;19:35–46.

Article  Google Scholar 

Rakovitch E, Gray R, Baehner FL, et al. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies. Breast Cancer Res Treat. 2018;169:359–69.

CAS  Article  Google Scholar 

Bartel D. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell Press. 2004;116:281–97.

CAS  Google Scholar 

Cannell IG, Kong YW, Bushell M. How do microRNAs regulate gene expression? Biochem Soc Trans. 2008;36(Pt 6):1224–31. https://doi.org/10.1042/BST0361224 (PMID: 19021530).

CAS  Article  PubMed  Google Scholar 

Hobert O. Gene regulation by transcription factors and microRNAs. Science. 2008;319(5871):1785–6. https://doi.org/10.1126/science.1151651 (PMID: 18369135).

CAS  Article  PubMed  Google Scholar 

Gong X, Sun J, Zhao Z. Gene regulation in glioblastoma: a combinatorial analysis of microRNAs and transcription factors. Int J Comput Biol Drug Des. 2011;4(2):111–26. https://doi.org/10.1504/IJCBDD.2011.041006 (Epub 2011 Jun 28 PMID: 21712563).

Article  PubMed  Google Scholar